HOME >> BIOLOGY >> NEWS
Classical subject underpins new biomedical advances

The ancient art of physiology -- the study of how the body works and how to repair it when things go wrong--has seen an upsurge in importance as it now plays a key role in the understanding of how genes work to support the human body.

At his inaugural lecture on Thursday (17 March), University of Edinburgh Professor Michael J. Shipston will say that our ability to isolate, manipulate and visualise gene products in cells and whole animals has revolutionized the understanding of the body and its functions. This in turn has caused a rise in demand for scientists with physiological training, to fully exploit these advances.

He will say: "This classical subject was described by Aristotle as the study of the whole organism and its component parts. It is now at the forefront of current biomedical advances as it seeks to understand how the catalogue of our genes, the human genome, is exploited to generate and maintain the human body."

Michael J. Shipston, Professor of Physiology and Director of the Centre for Integrative Physiology at the University, will discuss the importance of communication within and between cells of the body, in order to keep its 30kg of cells warm, fed and able to reproduce in 20 litres of water. To achieve this, cells need to overcome a major paradox -- the transfer of information, nutrients and waste products across fatty cell membranes which are designed to limit the transfer of these important molecules in order to keep the cell's environment separate from that of its neighbours.

He will say that art influences his approach to science, as by visualising the body's life processes, such as cells releasing hormones or single molecules in motion, he is able to obtain new insights into the basic processes which make the body work.

Physiology and the Art of Communication by Professor Michael Shipston, College of Medicine and Veterinary Medicine, University of Edinburgh: Thursday, 17 March 2005 in the Anatomy Lec
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
16-Mar-2005


Page: 1 2

Related biology news :

1. Pavlovs cockroach: Classical conditioning of salivation in an insect
2. A prickly subject: The sea urchin genome is sequenced
3. Fruit flies aboard space shuttle subjects of UCF, UC Davis study on immunity and space
4. Student work in human subjects protection sought for FDA conference at UH
5. New proteomics research promises to revolutionize biomedical discovery
6. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
7. Methodist, University of Houston, Cornell combine biomedical imaging expertise
8. Research center unites biomedical competitors to fund medical technology development
9. UT Metroplex institutions to collaborate on biomedical research
10. APS President-Elect Carey urges 6.7 percent increase for biomedical research
11. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Classical subject underpins new biomedical advances

(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/26/2015)... 26, 2015   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today reported ... goals, other key objectives, and financial guidance.  Synageva,s ... at 4:30 p.m. EST to review the financial ... participate in today,s call by telephone, please dial ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
(Date:2/26/2015)... February 26, 2015 Already well respected ... line by expanding its Length Gauge offerings with new ... , Specifically, HEIDENHAIN’s pencil probe-style SPECTO length ... specification. Two new 1Vpp, 12mm stroke length variants ... applications. One is a variant with a weak spring, ...
(Date:2/26/2015)... 26, 2015 Regis Technologies announced ... of oncology drug substances. , Regis Technologies is proud ... new Potent Compound Suite (PCS) for 2015. , Regis ... foot, cGMP facility in Morton Grove, Illinois. The PCS ... potent compounds up to about one kilogram per batch. ...
Breaking Biology Technology:Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2
Cached News: